A randomized controlled trial included 19 children with CD, and the mucosal healing rate in EEN was 89%.[16] The initial treatment with IFX was consistent with international guidelines recommending anti-TNF agents for pediatric CD. The gene discussed is TNF; the disease is Cowden disease.